EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Machine Learning Algorithm Suggests Repurposing Opportunities for Targeting Selected GPCRs

Shayma El-Atawneh iD, Amiram Goldblum iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms251810230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Shayma El-Atawneh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Modelling and Drug Design Lab, Institute for Drug Research and Fraunhofer Project Center for Drug Discovery and Delivery, Faculty of Medici…. Hauptthemen laut MEDLINE: Machine Learning, Drug Repositioning, Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Repurposing utilizes existing drugs with known safety profiles and discovers new uses by combining experimental and computational approaches. The integration of computational methods has greatly advanced drug repurposing, offering a rational approach and reducing the risk of failure in these efforts. Recognizing the potential for drug repurposing, we employed our Iterative Stochastic Elimination (ISE) algorithm to screen known drugs from the DrugBank database. Repurposing in our hands is based on computer models of the actions of ligands: the ISE algorithm is a machine learning tool that creates ligand-based models by distinguishing between the physicochemical properties of known drugs and those of decoys. The models are large sets of “filters” made out, each, of molecular properties. We screen and score external sets of molecules (in our case- the DrugBank molecules) by our agonism and antagonism models based on published data (i.e., IC50, Ki, or EC50) and pick the top-scoring molecules as candidates for experiments. Such agonist and antagonist models for six G-protein coupled receptors (GPCRs) families facilitated the identification of repurposing opportunities. Our screening revealed 5982 new potential molecular actions (agonists, antagonists), which suggest repurposing candidates for the cannabinoid 2 (CB2), histamine (H1, H3, and H4), and dopamine 3 (D3) receptors, which may be useful to treat conditions such as neuroinflammation, obesity, allergic dermatitis, and drug abuse. These sets of best candidates should now be examined by experimentalists: based on previous such experiments, there is a very high chance of discovering novel highly bioactive molecules.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningDrug RepositioningReceptors, G-Protein-CoupledHumansAlgorithmsLigandsDrug Discovery

Stichwörter der Autor:innen

GPCRsISEcannabinoid 2 receptorsdopamine receptorsdrug discoveryhistamine receptorsmachine learningrepurposing

Substanzen

Receptors, G-Protein-CoupledLigands

Autor:innen und Institutionen

  • Molecular Modelling and Drug Design Lab, Institute for Drug Research and Fraunhofer Project Center for Drug Discovery and Delivery, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112001, Israel.

ORCID-Profile: Shayma El-Atawneh, Amiram Goldblum

Zitieren

APA

El-Atawneh, S., & Goldblum, A. (2024). A Machine Learning Algorithm Suggests Repurposing Opportunities for Targeting Selected GPCRs. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251810230

Vancouver

El-Atawneh S, Goldblum A. A Machine Learning Algorithm Suggests Repurposing Opportunities for Targeting Selected GPCRs. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251810230

BibTeX
@article{ElAtawneh2024,
  author = {El-Atawneh, Shayma and Goldblum, Amiram},
  title = {A Machine Learning Algorithm Suggests Repurposing Opportunities for Targeting Selected GPCRs},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms251810230}
}
Kostenlos starten →